Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research.

Ferreira da Silva, Renato; Silva, Ana Marta; Morato, Manuela; Ribeiro-Vaz, Inês; Polónia, Jorge Junqueira

Ferreira da Silva, Renato; Silva, Ana Marta; Morato, Manuela; Ribeiro-Vaz, Inês; Polónia, Jorge Junqueira.

Ferreira da Silva R; Porto Pharmacovigilance Centre, Faculty of Medicine of the University of Porto, Porto, Portugal.
Silva AM; Department of Community Medicine, Health Information and Decision, Faculty of Medicine of the University of Porto, Portugal.
Morato M; CINTESIS - Center for Health Technology and Services Research, Porto, Portugal.
Ribeiro-Vaz I; Porto Pharmacovigilance Centre, Faculty of Medicine of the University of Porto, Porto, Portugal.
Polónia JJ; Department of Community Medicine, Health Information and Decision, Faculty of Medicine of the University of Porto, Portugal.

J Clin Pharmacol ; 63(5): 521-525, 2023 05.

Article in English | MEDLINE | ID: covidwho-2295018

Subject(s)

Antiviral Agents; COVID-19; Humans; Antiviral Agents/therapeutic use; Pharmacoepidemiology; Research Design

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Clin Pharmacol Year: 2023 Document Type: Article Affiliation country: Jcph.2195

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google